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Methods: Sixty-nine bifurcation lesions with angiographically ~50% diameter Stenosis 
were included in this study. An IVUS cross-section containing the main artery and the 
proximal part of the side branch analyzed for each lesion. We defined 2 types of bifurca- 
tion lesions according to the relation between the side branch and main artery in cross- 
sectional plane. Lesions were in Group A if longitudinal axis of the side branch was 
toward the center of the main atery and were in Group B if this axis was angulated 
toward the edge of main vessel instead of center (figure). In order to compare plaque dis- 
tribution between the groups, plaque thickness at 90”, 180” and 270” were measured by 
centering the geometric center of the lumen and were expressed clockwise from the side 
branch 
Results: Thirty-eight % of the lesions were in group B. Plaque distribution around the 
side branch was different in groups. Maximum plaque thickness was at 180” in group A 
and at 270” in group B (table) 
main >= 50%, prior CABG, or emergencies. Cox proportional hazards models were used 
for adjusted comparison of 5-year survival. 
Results: From 1992-1996, 6,272 patients met study criteria (31.3% PCI, 68.7% CABG). 
CABG patients were more likely to be > 70. to have 3VD, COPD, EF < 40%, LVEDP > 
22, but less likely to require urgent procedures. Adjusted in-hospital mortality was higher 
for CABG than for PCI (1.57% v 0.05%, p=O.O02). Overall, CABG was associated with a 
small improvement in survival compared to PCI (Table). However, 5-year survival was 
comparable for patients with 2VD. The improved survival associated with CABG was 
confined to patients with 3VD, 91.2% of these had CABG. 
Conclusion: Like BARI, we found similar survival for patients with 2VD in PCI and CABG. 
Unlike BARI, we found a survival benefit for CABG over PCI for patients with 3VD. This 
may reflect unmeasured differences in patients introduced by our registry setting or pro- 
cedural characteristics, such as completeness of revascularization. This observation may 
be used to inform physician and patient decision making. 
Conclusion: The side branch take-off angle rn the cross-sectionally plane influences the 
plaque distribution in bifurcation lesions. In angulated take-offs, atheroma close to the 
ostium may pose a higher risk for side branch occlusion during coronary interventions. 
1005-213 Percutaneous Interventions in Radial Artery Grafts: 
Clinical and Angiographic Outcomes 
Arvind Sharma, Andrew E. Ajani, Edouard F. Cheneau, Nidhi Garg. Afework 
GebreEyesus. Lowell F. Satkr, August0 D. Pichard, Ellen Pinnow, Ron Waksman, 
Joseph Lindsay, Washington Hospital Center, Washington, DC 
Background: As arterial grafts are replacing venous grafts for coronary artery bypass 
surgery (CABG), there has been an increasing demand for percutaneous interventions 
(PCI) for these conduits. While PCI of internal mammary artery (IMA) grafts has been 
extensively reported, experience with radial artery grafts is limited. We sought to evalu- 
ate the outcomes of 22 patients who underwent PCI of aortocoronary radial grafts. 
Methods: We analyzed the baseline clinical and angiographic characteristics, and 12- 
month outcomes of 22 consecutive patients (26 lesions) who underwent PCI of radial 
grafts between January 1998 and December 2901. 
Results: All patients presented with unstable angina, the majority (82%) within 14 
months of CABG. Angiographic success was achieved in 96%. The lesion location was 
evenly distributed: proximal anastomosis 9126 (35 %). shafl IO/26 (38 %), and distal 
anastomosis 7/26 (27 %). Stems were deployed in 50% of lesions. There were no proce- 
dural complicabons or In-hospital cardiac events. Clinical follow-up was available in all 
patients, with angiographic follow-up in 77%. The mean follow-up was 392 * 363 days. 
There were no deaths or myocardial infarctions; 16 patients (73%) had stable angina. 
Restenosis occurred in IO/22 (45%) patients or IO/26 (36%) lesions. Ninety percent of 
restenosts occurred within 7 months. Restenosis occurred in 719 (78%) of proximal anas- 
tomosis. 3110 (30%) shaft, and O/i’ (0%) distal anastomosis. 5/10 (50%) of these rest- 
enotic lesions were treated with balloon alone. 
Conclusion: Percutaneous revascularization of radial grafts can be performed safely 
with high procedural success. However, compared to the published experience in IMA 
grafts, radial graft interventions have a higher restenosis rate, particularly at the proximal 
anastomosis. 
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1005A-210 Survival Following Percutaneous Coronary 
Interventions Versus Coronary Artery Bypass Graft in 
Northern New England 
Daniel J. O’Rourke, Davrd J. Malenka, Gerald T. O’Connor, John F. Robb, Mirle A. 
Kellett, Jr., Lawrence J. Dacey, Michael A. Hearne, Nathaniel W. Niles, Thomas J. Ryan, 
Jr., Theodore M. Silver, Hebe 8. Quinton, Dartmouth-Hitchcock Medical Center, 
Lebanon, NH, Northern New England Cardiovascular Disease Study Group, Lebanon, 
NH 
Background: BARI reported that nondiabetic patients with multivessel coronary disease 
had comparable 5 year survival with PCI or CABG. We examined the generalizability of 
these findings using consecutive cases of nondiabetic patients in Northern New England. 
Methods: Patient characteristics and long-term survival were compared for PCI and 
CABG patients with multivessel disease, excluding those with diabetes, cancer, lVD, left 
3A 
Patients N (%PCI) Adjusted HR 95% Cl P= 5 Yr Survival 
PCI ” CABG PCI, CABG (%) 
2VD 3890 (44.5) 1.24 0.91, 1.69 0.167 88.6, 88.7 
3VD 2382 (9.8) 1.87 1.17, 3.01 0.099 84.4,94.7 
All 6272 (31.3) 1.36 1.05, 1.78 0.021 89.6, 91.6 
1005A-211 Vascular Disease Independently Predicts Worse 
Outcome After Percutaneous Coronary Intervention: 
Results From the NHLBI Dynamic Registry 
Srihari S. Naidu, Helen A. Vlachos, David Faxon. Alice K. Jacobs, Janet M. Johnston, 
Katherine Detre,Robert L. Wilensky. Hospital of the University of Pennsylvania, 
Philadelphia, PA, University of Pittsburgh, Pittsburgh, PA 
Backgrounct While vascular disease (VD) is considered a risk factor for adverse out- 
come after coronary artery bypass grafting (CABG), it is unknown whether VD predicts 
poorer outcome after percutaneous coronary intervention (PCI). This multi-center study 
utilizing the NHLBI Dynamic Registry was designed to determine whether the current 
practice of PCI in patients with VD is associated with worse outcome when compared to 
patients without VD. Methods: VD was defined as a history or presence of stroke, tran- 
sient ischemic attack, claudication. vascular bypass, amputation or aortic aneurysm. The 
incidences of death, myocardial infarction (Ml), CABG, repeat PCI and repeat revascular- 
ization were prospectively collected on 4,629 consecutive patients who underwent PCI in 
17 centers between July, 1997 and February, 1998 and February and June, 1999. Proce- 
dural, in-hospital and one-year outcomes in patients with VD (n=554) were compared to 
patients without VD (NVD, n=4,075). Results: VD patients were more likely older, 
female, smokers and white, and were more likely to have multi-vessel disease, reduced 
ejection fraction, hypertension, diabetes, heart failure and hypercholesterolemia. While 
rates of stenting were equivalent between VD and NVD patients (71.5% vs. 73.0%, 
p=NS), total angiographic euccess was lower in patients with VD (89.5% vs. 93.2%, 
pcO.01). VD patients had more death (2.7% vs. 1.3%, pcO.O5), Ml (4.7% vs. 2.6%, 
p<O.Ol), CABG (2.2% vs. l.l%, ~~0.05) stroke (1.1% vs. 0.2%, pcO.001) and major 
entry site complication (6.7% vs. 3.5%, p<O.OOl) during the index hospitalization. At one- 
year, VD patients continued to have more death (10.5% vs. 4.5%, pcO.001) and MI (9.2% 
vs. 5.2%. p<O.OOl). Aner adjusting for clinical, demographic, and angiographic differ- 
ences, VD was independently associated with worse death/Ml (OR 1.4, 95% Cl 1.1-I 8) 
and death/MI/CABG (RR 1.3,95% Cl 1.1-I .6) at one year.Conclusion: Patients under- 
gorng PCI with vascular disease have more co-morbidities than patients without. After 
adjusting for these co-morbidities. vascular disease remains an independent predictor of 
worse outcome at one year and should be considered when choosing a revascularization 
strategy. 
1005A-212 First Multi-Center Experience With a Novel Low-Profile 
Filter-Wire Distal Protection Device (Interceptor ) 
During Saphenous Vein Graft Stenting 
Dean J. Kereiakes, Abram C. Rabinowitz. Richard F. Ammar. John J. Young, Chandan 
Vinekar, Camvbell D K. Roaers. The Lindner Center/Ohio Heart Health Center, 
Cincinnati, OH 
Atheroembolism commonly follows stenting of saphenous vein graft (SVG) conduits and 
may contribute to adverse clinical outcomes. Filter distal protection devices (DPD) offer 
advantages over the FDA approved balloon occlusive device which Include maintenance 
Of coronary flow, angiographic visibility and single operator use. Potenbal limitations 
include device profile, filter pore size and single use capability. A novel 0.039 inch nitinol 
wire filter DPD (InterceptorTM) was deployed during SVG stenting in a multicenter trial. 
Methods: Patients (n=25) with mean age 71 years (85% male, 40% diabetic, LVEF 
9.40 38%) undergoing stenting of SVG (mean age IO years) de nova e&noses (mean 
lesion length 3.5 mm; thrombus 72%; $2 ACCIAHA lesion class 68%) with Intercep- 
torT” DPD were analyzed. TIMI flow pre-procedure (28% TIMI 2, 72% TIMI 3) was 
improved post-procedure (8% TIMI 2, 88% TIMI 3). Procedural and hospital outcomes 
are summarized (Table) 
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Procedure Success 
Device Success 
Any MACE’ 
Death 
Q-wave MI 
Non-Q wave MI# 
TVR (Surgical or percutaneous) 
Final TIM1 Flow 
92% (23/25) 
96% (24/25) 
8% (2/25) 
0% 
0% 
8% (2/25) 
4% (1125) 
2.8 * 0.7 (24) 
(0.0, 3.0) 
*Death, Q or Non-Q MI. Emergency TVR: #CK-MB > BXULN; TVR -target vessel 
revascularization 
Conclusions: This preliminary experience suggests that the novel low-profile Intercep- 
torTM filter wire appears safe and effective in reducing atheroembolism during stenting of 
complex SVG stenoses. A randomized trial comparison with approved standard is 
planned. 
1005A-213 Hemoglobin Level Is an Independent Predictor of 
Mortality in Patients Undergoing Percutaneous 
Coronary Artery Interventions 
Hitinder S. Gurm, Ritesh Gupta, Michael S. Lauer, Russel Raymond, Stephen G. Ellis, 
The Cleveland Clinic Foundation, Cleveland. OH 
Background: Anemia is a powerful predictor of mortality in patients with congestive heart 
failure. The significance of anemia in patients with coronary artery disease is unknown. 
Methods: We studied 4309 patients undergoing percutaneous coronary intervention 
(PCI) from October 1996 to August 2001 stratified by their pre-procedural hemoglobin 
levels into quartiles. There were 1051 patients in 1 St quartile (mean lib 10.80, range 6.7. 
12.0g/dl), 1077 in 2”d quartile (mean Hb 12.75 g/dl, range 12.1.13.39/dl), 1135 in the 3” 
quartile (mean Hb 13.93 gldl, range 13.4-14.5 g/dl), and 1046 patients in the 4’“quartile 
(mean Hb15.37 g/dl, range 14.6-18.0 g/dl). Patients were followed for a median of 3 
years after the PCI. Results: There were 228 (22%) deaths in the 1 J’quactile, 116 (11%) 
deaths in the 2ti quartile, 75 (7%) deaths in the 9 quartile, and 61 (6%) deaths in the 
4’h quartile. An increase of 1 gmJdl in pre-procedural Hb level was associated with a sig- 
nificant reduction in hazard rate of death after PCI (hazard ratio 0.70, 95%CI 0.67 to 
0.74, p<O.OOl). The association remained strong after adjusting for age, gender, white 
blood cell count, serum creatinine, left ventricular ejection fraction, acute myocardial inf- 
arction, diabetes, ACC lesion score, adjunct medications and site of lesion (HR 0.841. 
95% Cl 0.79 - 0.89, p ~0.001) Conclusion: A lower pre-procedural Hb level, even in the 
range considered to be normal. is associated with increased long-term mortality in 
patients undergoing PCI. 
1005A-214 Does Coronary Angioplasty Lead to Accelerated 
Progression of Non-Critical Corsnary Artery Stenoses? 
Zaza J. Aivazi, Lev Lubarsky. Anastasia Nikitina, Milena G. Adamian, Ali Aboufares. 
Eugene C. DePasquale, Julia Adamian, Yelena Pertsovsky, Jeffrey Moses, Neil Coplan, 
lssam Moussa, Lenox Hill Hospital, New York, NY 
Background: It has been suggested that coronary intervention may provoke progression 
in non-critical stenoses due to wire trauma or unintended manipulation. This study was 
performed to determine whether index coronary allery intewention leads to accelerated 
progression of non-critical coronary disease. 
Methods: The study included 90 pts with 186 non-critical coronary artery stenoses 
(diameter stenosis, DS ~50%) that had paired angiograms separated by more than 6 
months. Non-critical stenoses were divided into two groups: Group I - stenosis located in 
the angioplasted arteries (n=51) and Group II - stenosis located in a non-culprit arteries 
(n=135). Angiographic analysis was performed using the MEDIS-QCA-CMS system. Dis- 
ease progression was defined as an increase in DS by z-15%. 
Results: Pts mean age was 6k_12 yrs and 77% were males. Diabetes and hyperlipe- 
demia were present in 37% and 79%, respectively. The paired angiograms were sepa- 
rated by a mean of 8+2 months. Baseline DS was 3&l 1% and at follow-up increased to 
38~13%. Significant progression occurred in 30 stenoses (16%) with a mean change in 
DS of 21+6%. Disease progression was independent of tobacco, diabetes, or hyperlipe- 
demia. 
Comparison of Groups I and II is shown: 
Group I(n=51) Group II P value 
(n=135) 
Progression 9 (18%) 21 (16%) NS 
Mean change in DS (%) 23+s 219 NS 
‘Conclusion: Progression of non-critical coronary disease occurs in a minority of 
stenoses 8 months after angioplasty. Index intervention did not lead to accelerated dis- 
ease progression in manipulated coronary arteries compared to other atteries. 
1005A-215 Baseline Plasma Creatinine Is an Independent Predictor 
of In-Hospital Mortality After Percutaneous Coronary 
Intervention 
Vladimir Dzavik. Cynthia Jackevicius, Steven Miner, Alan Barolet. Karen Mackie, John 
Ross, Peter Seidelin, Toronto General Hospital, Toronto, ON, Canada 
Background: Patients with established renal failure (RF) are at an increased risk of 
adverse events and mortality following percutaneous coronary interventions (PCI). The 
outcome in those with mild RF is less clear. The main aim of this study was to determine 
the rates of in-hospital events after PCI in patients with normal renal function, mild RF 
and moderate to severe RF. Secondly we sought to determine if plasma creatinine at 
baseline is an independent predictor of in-hospital adverse outcome after PCI. Methods: 
We analyzed all consecutive PCI cases performed at the Toronto General Hospital 
between April 1. 2001 and March 30. 2002 and entered into a prospective database. 
Patients were divided into 3 groups: baseline serum creatinine (Cr) 180umoUl (Group C). 
The in-hospital outcomes for each subgroup were compared and independent predictors 
of death were determined by multiple regression analysis. Results: A total of 2011 PCI 
cases were performed. There were 1772 subjects in Group A (mean age 62*1 lyrs). 152 
subjects in Group B (68+lOyrs) and 86 subjects in Group C (68+12yrs). In-hospital mor- 
tality was 0.8%, 5.9% and 7.0% in groups A, B and C respectively (pcO.0001); mortality. 
myocardial infarction (MI) and abrupt closure (AC) occurred in 3.0%, 6.6% and 10.5% of 
patients in Groups A, Band C respectively (p=O.o002). Prior Ml (pcO..OOOl), case acuity 
(p<O.OOOl), age (p<O.OOOl) baseline creatinine (p=.OOO2), and diabetes (p=O.OOS) were 
identified as independent predictors of in-hospital mortality following PCI. 
Conclusion: Baseline renal function is a powerful independent predictor of in-hospital 
mortality and other adverse events after PCI. Even mild elevation in baseline serum cre- 
atinine is associated with a substantial increase in mortality risk. This should be taken 
into account by the intewentional cardiologist when considering a patient for a percuta- 
neous coronary interventional procedure. 
1005A-2 16 International Trends in the Use of Primary 
Percutaneous Coronary Intervention 
Mark J. Eisenberg, Kristian B. Filion, Abigail Moreland, Olga Saynina, Louise Pilate, For 
the TECH Investigators. Jewish General Hospital/McGill University, Montreal, PO, 
Canada 
Background: Primary percutaneous coronary intervention (PCI) is an effective treatment 
for acute myocardial infarction (AMI). However, little is known about international trends 
in the use of this technology. 
Objective: To examine international trends in the use of primary PCI. 
Methods: National databases and large regional databases were used to examine 
aggregate data for AMI patients from 5 countries (Canada, Denmark, England, Sweden, 
and the United States (U.S.)), with data covering the period of 1990-1999. Data were 
standardized for age and sex using the 1995 United States AMI patient cohort. 
Results: We found that, in all countries, patients receiving primary PCI were younger 
and more likely to be male compared to AMI patients not receiving PCI. The use of pri- 
mary PCI varied widely with the highest use in the U.S. (12.4% among AMI patients < 65 
years old in California; 6.9% among U.S. Medicare AMI patients 265 years old) and the 
lowest in England (0.3% of all AMI patients). The U.S., with the earliest start and most 
rapid growth in primary PCI usage, were the international leaders in primary PCI use 
(Table). In most countries, patients receiving primaly PCI had lower in-hospital mortality 
rates and, in all countries, they had shorter lengths of stay. Lower mortality rates and 
shorter lengths of stay among primary PCI patients were maintained at 90 days post- 
AMI. 
Conclusions: Important international variations exist in the use of primary PCI. 
